Prevention of thromboembolic events in gynaecological practice
https://doi.org/10.30629/0023-2149-2021-99-11-12-593-601
Abstract
The review presents current data on the prevention of thromboembolic events in operative gynecology. Specifi c attention is paid to the determination of the clinical expectancy of thrombotic events, the stratifi cation of patients by risk groups, taking into account surgical and extragenital pathology, the peculiar features of surgical intervention, the use of laboratory and instrumental techniques, as well as the duration and the extent of pharmacological prevention of thromboembolic events after surgery.
About the Authors
A. P. Melnikov
Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation
Russian Federation
Melnikov Andrey P.
101000, Moscow
M. G. Shcherbatykh
Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation
Russian Federation
Shcherbatykh Marina G.
101000, Moscow
References
1. Bokarev I.N. Venous thromboembolism and pulmonary embolism. Moscow: MIA, 2005:205. (in Russian)
2. ESC recommendations for the diagnosis and management of patients with acute pulmonary embolism. Russian Journal of Cardiology. 2015;8:67–110. (in Russian)
3. Dukhin A.O. Prevention of venous thromboembolic complications in the surgical treatment of patients with gynecological diseases. Attending Physician. 2014;3:48–51. (in Russian)
4. Ozolinya L.A. Venous thromboembolic complications in obstetrics and gynecology. Monograph. GEOTAR-Media. 2015:256. (in Russian)
5. Tikhomirov A.L. Prevention of thromboembolic complications in the postoperative period in gynecology. Gynecology. 2006;8(1):41–43. (in Russian)
6. White R.H. The Epidemiology of Venous Thromboembolism. Circulation. 2003;107(23):14–18.
7. Glushkov N.I. Our experience in the prevention of postoperative venous thromboembolic complications in elderly and senile patients. Bulletin of St. Petersburg. Medical Academy of Postgraduate Education. 2011;3:38–42. (in Russian)
8. Goldhaber S.Z., Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835–1846.
9. Murin S., Romano P.S., White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embo lism. Thromb. Haemost. 2002;88:407–414.
10. Watson H. et.al. Guideline on aspects of cancer-related venous thrombosis. Br. J. Haematol. 2015;170(5):640–8.
11. Kartasheva A. Pulmonary embolism. New ESC Recommendations (2008). Medicine Review. 2008;4:56–64. (in Russian)
12. Keeling D., Tait R.C., Watson H. Peri-operative management of anticoagulation and antiplatelet Therapy. British Committee for Standards in Haematology. British Journal of Haematology. 2016;175:602–613.
13. Kulakov V.N. Intensive care in obstetrics and gynecology. Moscow: Medical Information Agency. 1998:206. (in Russian)
14. Kesteren P., Hanley J., Lotigbney A.D. Pregnancy-associated venous thrombosis. Phlebology. 2012;27:73–80.
15. Qu H., Li Z., Zhai Z., Liu C., Wang S., Guo S., Zhang Z. Predicting of Venous Thromboembolism for Patients Undergoing Gynecological Surgery. Medicine (Baltimore). 2015;94(39):1653.
16. Mahan C.E. Venous thromboembolism pharmacy intervention management program with an active, multifaceted approach reduces preventable venous thromboembolism and increases appropriate prophylaxis. Clin. Appl. Thromb. Hemost. 2012;18:45–58.
17. Amin T., Cohen H., Wong M., Goodhart V., Pointer S.L., Jurkovic D. The prevalence of incidental uterine venous plexus thrombosis in women attending a gynecology clinic. J. Thromb. Haemost. 2020;18(10):2557–2565.
18. Buyanova S.N. Features of prevention of thromboembolic and purulent septic complications in surgical gynecology. Russian Bulletin of Obstetrician-Gynecologist. 2016;16(6):38–46. (in Russian)
19. Pretorius L., Thomson G.J.A., Adams R.C.M., Nell T.A., Laubscher W.A, Pretorius E. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc. Diabetol. 2018;17(1):141.
20. Cavender M.A., Steg P.G., Smith S.C. Jr., Eagle K., Ohman E.M., Goto S., Kuder J., Im K., Wilson P.W., Bhatt D.L. REACH Registry Investigators. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circulation. 2015;132(10):923–31.
21. Kirienko A.I., Leontiev S.G., Lebedev I.S., Seliverstov E.I. Prevention of venous thromboembolic complications in surgical practice. Consilium Medicum. 2006;8(7):78–80. (in Russian)
22. Fernandes C.J., Morinaga L.T.K., Alves J.L. Jr., Castro M.A., Calderaro D., Jardim C.V.P., Souza R. Cancer-associated thrombosis: the when, how and why. Eur. Respir. Rev. 2019;28(151):180119.
23. Suzuki N., Yoshioka N., Ohara T., Yokomichi N., Nako T., Yahagi N., Igarashi S., Kobayashi Y., Yoshimatsu M., Takizawa K., Naka jima Y., Kiguchi K., Ishizuka B. Risk factors for perioperative venous thromboembolism: A retrospective study in Japanese women with gynecologic diseases. Thromb. J. 2010;8:17.
24. Shiota M., Kotani Y., Umemoto M., Tobiume T., Tsuritani M., Shimaoka M., Hoshiai H. Deep-vein thrombosis is associated with large uterine fi broids. Tohoku J. Exp. Med. 2011;(2):87–9.
25. Geerts W.H., Heit J.A., Clagett G.P., Pineo G.F., Colwell C.W., Anderson F.A., Wheeler H.B. Prevention of venous thromboembolism. Chest. 2001;119(1):132–175.
26. Spotnitz W.D. Active and mechanical hemostatic agents. Surgery. 2007;142:34–8.
27. Wright J.D., Ananth C.V., Lewin S.N., Burke W.M., Siddiq Z., Neugut A.I., Herzog T.J., Hershman D.L. Patterns of use of hemostatic agents in patients undergoing major surgery. J. Surg. Res. 2014;186(1):458–66.
28. Buyanova S.N. et al. Determination of high risk factors for thromboembolic complications in the postoperative period in women with gynecological diseases that impair the function of adjacent organs. Algorithm for diagnostics and prevention. Information and methodological letter. 2019. (in Russian)
29. Wells P.S. Integrated strategies for the diagnosis of venous thromboembolism. J. Thrombosis Haemostasis. 2007;5(s1):41–50.
30. Pomero F., Dentali F., Borretta V, Bonzini M., Melchio R., Douketis J.D., Fenoglio L.M. Accuracy of emergency physicianperformed ultrasonography in the diagnosis of deep-vein thrombosis: a systematic review and meta-analysis. Thromb. Haemost. 2013;109(1):137–45.
31. Edited by Yu.L. Shevchenko, Yu.M. Stoyko. Fundamentals of clinical phlebology, 2nd edition. Textbook, 2013. (in Russian)
32. Yakovlev V.B. Pulmonary embolism. Cardiology. 2005. (in Russian)
33. Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Heart Journal. 2008;29:2276–2315.
34. Shi J., Ye J., Zhuang X., Cheng X., Fu R., Zhao A. Application value of Caprini risk assessment model and elevated tumor-specifi c D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies. J. Obstet. Gynaecol. Res. 2019;45(3):657–664.
35. Kjellberg U., Hellgren M. Sonoclot signature during normal pregnancy. Intensive Care Med. 2000;26(2):206–11.
36. Hemker H.C., Al Dieri R., Beguin S. Curr. Opin. Hematol. 2004;11:170–175.
37. Serebriyskiy I.I. «Global» and «local» tests of the hemostasis system in the diagnosis of hypercoagulable syndrome. Reference book of the head of the clinical diagnostic laboratory. 2012;12. (in Russian)
38. Hartert H. et al. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungs verfahren. J. Klin. Wochenschrift. 1948;26:577–583.
39. Gould M.K., Garcia D.A., Wren S.M., Karanicolas P.J., Arcelus J.I., Heit J.A., Samama C.M. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e227S–e277S.
40. Sang C.Q., Zhao N., Zhang J., Wang S.Z., Guo S.L., Li S.H., Jiang Y., Li B., Wang J.L., Song L., Zhai J.J., Zhang Z.Y. Diff erent combination strategies for prophylaxis of venous thromboembolism in patients: A prospective multicenter randomized controlled study. Sci. Rep. 2018;8(1):8277.
41. Feng J.P., Xiong Y.T., Fan Z.Q., Yan L.J., Wang J.Y., Gu Z.J. Effi cacy of intermittent pneumatic compression for venous thromboembolism prophylaxis in patients undergoing gynecologic surgery: A systematic review and meta-analysis. Oncotarget. 2017;8(12):20371–20379.
42. Emelyanov D.N., Sergeev V.S. Anticoagulants in cardiological practice. Medicinal Herald. 2013;7(3):20–26. (in Russian)
43. Gilyarov M.Yu. Rivaroxaban in the prevention of thromboembolic complications in patients with atrial fi brillation. Rational pharmacotherapy in cardiology. 2012;8(3):453–456. (in Russian)
44. Lip G.Y., Nieuwlaat R., Pisters R. et al. Refi ning clinical risk stratifi cation for predicting stroke and thromboembolism in atrial fi brillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fi brillation. Chest. 2010;137:263–272.
45. Franchi L., Patrelli T.S., Berretta R., Rolla M., Gizzo S., Gramellini D., Bacchi Modena A., Nardelli G.B. Role of D-dimer testing in severe pelvic infl ammatory disease: a new usable marker to assess the need for fertility-impairing surgery? Fertil. Steril. 2010;94(6):2372–5.
46. Liu J., Wang N., Chen Y., Lu R., Ye X. Thrombelastography coagulation index may be a predictor of venous thromboembolism in gynecological oncology patients. J. Obstet. Gynaecol. Res. 2017;43(1):202–210.
47. Nates J.L., Aravindan N., Hirsch-Ginsberg C., Sizer K.C., Kee S, Nguyen A.T., Chen K., Shaw A.D., Price K.J. Critically ill cancer patients are not consistently hypercoagulable after craniotomy. Neurocrit. Care. 2007;7(3):211–6.
Review
For citations:
Melnikov A.P., Shcherbatykh M.G. Prevention of thromboembolic events in gynaecological practice. Clinical Medicine (Russian Journal). 2021;99(11-12):593-601. (In Russ.) https://doi.org/10.30629/0023-2149-2021-99-11-12-593-601
Views:
527
Email this article 